Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 447

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 447
---
 objectives and the creation of stockholder value, while enabling Longevity to attract, motivate and retain individuals who contribute to the long-term success of Longevity. Except as indicated below, decisions on the executive compensation program will be made by the compensation committee of the Board. We also expect that Longevity will grant equity-based incentive compensation to our executive officers following the Closing. In connection with the Business Combination, Longevity approved payment of transaction bonuses to Bradford A. Zakes in the amount of $500,000 upon the Closing.

Director Compensation

To date, Longevity has not paid any compensation or fees, whether in cash or equity, to its sole director.

Following the Closing, Longevity intends to develop a compensation program for its directors designed to align compensation of its directors with Longevity’s business objectives and the creation of stockholder value. Decisions regarding the directors’ compensation program will be reviewed and recommended by the compensation committee of the Board and approved by the Board. We currently expect that Longevity will grant equity-based incentive compensation to our directors following the Closing.

New Equity Incentive Plan

The material terms of the Equity Incentive Plan are summarized under the Incentive Plan Proposal. It is anticipated that, as described further in the “Interests of Longevity’s and Targets’ Directors and Executive Officers in the Business Combination” section below, the Equity Incentive Plan will be first adopted prior to the Closing, subject to the approval of the Incentive Plan Proposal.

It is anticipated that equity-based compensation will be an important foundation in executive compensation following the consummation of the Business Combination to maintain a strong link between executive incentives and the creation of stockholder value. Neither specific grants nor formal guidelines

for the allocations of equity-based compensation have yet been determined, but it is expected that the Equity Incentive Plan described in Proposal No. 5 will be an important element of the new compensation arrangements for FutureTech.

Interests of Longevity’s and the Targets’ Directors and Executive Officers in the Business Combination

The directors and executive officers of Longevity and the Targets have interests in the Business Combination that are different from, or in addition to, those of their respective equity holders. The Longevity Board was aware of and considered these interests, among other matters, in reaching the determination to approve the terms of the Business Combination. These interests include, among other things, the interests listed below:

| ● | Certain                                                                                                                              
 of the directors and executive officers of Longevity and the Targets are expected to become directors and/or executive